Vitrafy Life Sciences Limited (ASX:VFY)

Market Cap	112.38M -7.6%
Revenue (ttm)	2.34M +51.9%
Net Income	-14.15M
EPS	-0.22
Shares Out	63.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,213
Average Volume	55,730
Open	1.760
Previous Close	1.760
Day's Range	1.675 - 1.760
52-Week Range	1.080 - 1.950
Beta	n/a
RSI	59.69
Earnings Date	Jan 28, 2026

About Vitrafy Life Sciences

Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company’s cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding p...

• Industry: Laboratory Apparatus and Furniture
• Founded: 2017
• Employees: 22
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VFY

Financial Performance

In fiscal year 2025, Vitrafy Life Sciences's revenue was 1.05 million, a decrease of -49.14% compared to the previous year's 2.06 million. Losses were -32.71 million, 213.8% more than in 2024.